Thoughts
Proteomics at a Crossroads: Why We Must Rethink Data Analysis
Proteomics is accelerating. Can our current tools keep up?
Scientific deep dives, product thinking, and perspectives on proteomics, reproducibility, and agent-ready science — from the team building Mass Dynamics.
Proteomics is accelerating. Can our current tools keep up?
Introduction: The Urgency of Multivariate Companion Markers in Precision Medicine
Introduction: A Paradigm Shift in Drug Discovery
From Left to Right: Dr Jamie Kuhar, Prof. Parag Mallick, Dr Fiona McAllister, Dr Francesco Pingitore, Assist. Prof. Ruth Huttenhain, Dr ...
It's hard to believe we're officially past the half way point of the year! Are you more than half way to achieving your goals? If you're ...
"If I have seen further, it is by standing on the shoulders of giants." Isaac Newton (1676). The scientific process of discovery is a slow ...
Technology is moving fast 💨 Here’s 'What’s New' at Mass Dynamics to help you, your team and Collaborators level-up 👀! Thank you for being ...
Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization March 06, 2023 ...
Hi there!, Welcome to the final #MassGeek Playbook for the year - a HUPO 2022 Special Edition! If you are new to the MassGeek Community, ...
MD 2.0 unleashes next level MSP insight generation In my opinion, MSP is one of the most exciting areas in biological research. By allowing ...